Pro-Dex, Inc. (PDEX) Financials

PDEX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 51.4 million 19.6 million
2023-09-30 51.8 million 20.2 million
2023-06-30 51.8 million 20.2 million
2023-03-31 47.0 million 21.1 million

PDEX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 77000 197000
2023-09-30 475000 182000
2023-06-30 475000 182000
2023-03-31 2.2 million 206000

PDEX Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 500000
2023-09-30 3.8 million
2023-06-30 3.8 million
2023-03-31 1.3 million

PDEX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 7.1 million - 1.4 million
2023-09-30 4.1 million - 1.5 million
2023-06-30 - - 1.6 million
2023-03-31 3.2 million 9.2 million 1.7 million

PDEX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 3.6 million
2023-09-30 3.6 million
2023-06-30 3.5 million
2023-03-31 3.6 million

PDEX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 633000 788000 1.2 million 37000
2023-09-30 152000 695000 1.0 million 9000
2023-06-30 152000 695000 1.1 million -
2023-03-31 135000 713000 1.0 million 24000

PDEX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 12.6 million 9.8 million
2023-09-30 10.6 million 7.3 million
2023-06-30 10.6 million 7.3 million
2023-03-31 13.1 million 9.3 million

PDEX

Price: $18.61

52 week price:
14.51
22.99

Payout Ratio Range:
81.38%
345.95%

Earnings Per Share: 0.84 USD

P/E Ratio: 12.82

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 13800

Ebitda: 3.9 million

Market Capitalization: 63.3 million

Links: